Home / Inspections / 1226102

FDA Inspection 1226102 — Amneal Pharmaceuticals, LLC

Amneal Pharmaceuticals, LLC — FEI 3008861605

The FDA completed an inspection of Amneal Pharmaceuticals, LLC on November 21, 2023 in Piscataway, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 21, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Piscataway, NJ (United States)

Facility

Other inspections at this facility

  • 1309420 (NAI Thu Apr 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1256805 (NAI Fri Mar 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1162045 (VAI Thu Feb 10 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1075997 (NAI Fri Oct 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 967059 (NAI Fri Feb 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources